Andera Partners
CIK 0001757283 · PARIS, null · Quarter end: 2026-06-30 · Filed on: 2026-07-22 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$206.5M
2026 Q2
Positions
8
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
KMTS
KESTRA MED TECHNOLOGIES LTD
33.6%
MLYS
MINERALYS THERAPEUTICS INC
20.8%
AVLN
AVALYN PHARMACEUTICALS INC
14.8%
AGMB
AGOMAB THERAPEUTICS NV
9.7%
EVMN
EVOMMUNE INC
9.0%
IVA
INVENTIVA SA
6.7%
ABVX
ABIVAX SA
5.0%
NYXH
NYXOAH S A
0.4%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.